ES75
TEAS SECTION 71 & 15 RECEIVED
05/29/2026
Back to search
Official data from USPTO
BIONTECH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
06/01/2026
Trademark type
Combined
Nice classes
1, 5, 42, 44
Filing date
04/05/2019
Registration date
06/02/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/02/2020
Last transaction
06/01/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
94
Owner location
DE
Examiner
HARDY LUDLOW, TARAH KIM
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "BIONTECH".
Holders and representatives
Holders
B. S. (pessoa física)
Representatives
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in industry and sciencein particular for use in biotechnologypharmaceuticsmedicine and veterinary medicine
Class 5
Pharmaceutical and veterinary preparationspreparations for the prevention and treatment of proliferative diseasescancersinfectious diseasesautoimmune diseasesexcept vitamin preparationsmineral food supplementsprobioticsomega 3 preparationsdietetic substances and food supplements for medical and non-medical purposes; vaccinesDNA-based and RNA-based vaccinesadjuvant preparations for use with vaccinesnucleic acids sequencesproteinschemical reagents for medical and veterinary purposesprotein conjugatespeptides featuring antibodies and tumour markers; cell-based immunotherapeutic treatment by way of genetically modified cellsmedicated serums for the treatment of proliferating diseasescancersinfectious diseasesautoimmune diseasesattenuated viruses and particles similar to virusesencapsulated nucleic acids; diagnostic reagents and diagnostic preparations for medical purposes
Class 42
Scientific research and development in the field of molecular biologybiotechnologypharmaceuticsimmunology and oncologyin particular research and development in the field of medical and veterinary diagnostics and therapy using molecular biologicalgenetic engineering and biotechnological methodsscientific research related to screening for pharmaceutically active compounds; scientific research and development of diagnostic methods and test processes; scientific research and development related to technical planning and conducting of projects in the field of the supplying of medicines; scientific consultancy services in the field of research and development of therapies and medical preparations; providing of scientific expertise in the nature of scientific study and research in the field of medicine; scientific research and development for medical and veterinary purposes; conducting and evaluating medical and pharmaceutical studiestestinganalysis and evaluation of goods/services of others to determine conformity with certification standards
Class 44
Medical services; providing medical care services and consultation related thereto; urgent medical care centers; pharmaceutical and medical consultancy; providing healthcare information and advisory services in the healthcare field; medical consultation services featuring preparation of reports relating to medical and pharmaceutical services; medical and pharmaceutical consultation; all the aforesaid services other than in the field of bione therapy or other types of therapy combined with bione therapy
Publications
History of USPTO decisions and trademark events.
38 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/07/2026
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/12/2026
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/02/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/24/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
02/24/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/24/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/24/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/24/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/24/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/15/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/18/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/28/2020
FIMP
FINAL DISPOSITION PROCESSED
09/28/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/02/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
06/02/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/17/2020
PUBO
PUBLISHED FOR OPPOSITION
03/17/2020
GPNX
NOTIFICATION PROCESSED BY IB
03/13/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/26/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/26/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/26/2020
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/13/2020
ALIE
ASSIGNED TO LIE
02/11/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/07/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/06/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/05/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/05/2020
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
10/24/2019
RFNT
REFUSAL PROCESSED BY IB
08/30/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/15/2019
RFRR
REFUSAL PROCESSED BY MPU
08/15/2019
MAFR
APPLICATION FILING RECEIPT MAILED
07/26/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/23/2019
CNRT
NON-FINAL ACTION WRITTEN
07/22/2019
DOCK
ASSIGNED TO EXAMINER
07/22/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/22/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/18/2019
Continuous trademark protection
Get notified about every new filing that threatens BIONTECH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.